Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03PXT
|
|||
| Former ID |
DIB011771
|
|||
| Drug Name |
Altastaph
|
|||
| Synonyms |
StaphGam; AltaStaph, Nabi; Next-generation Altastaph; Staphylococcus polyclonal Ab, Nabi; AltaStaph (adult formulation), Nabi; AltaStaph (neonatal formulation), Nabi
Click to Show/Hide
|
|||
| Indication | Staphylococcus infection [ICD-11: 1B5Y] | Phase 2 | [1] | |
| Company |
Nabi Biologics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00066989) Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.